PAI-1 inhibits urokinase-induced chemotaxis by internalizing the urokinase receptor

被引:63
作者
Degryse, B [1 ]
Sier, CFM [1 ]
Resnati, M [1 ]
Conese, M [1 ]
Blasi, F [1 ]
机构
[1] Univ Vita Salute San Raffaele, Dept Cell Biol & Funct Genet, DIBIT, Mol Genet Unit, I-20132 Milan, Italy
关键词
D O I
10.1016/S0014-5793(01)02797-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
PAI-1 (plasminogen activator inhibitor-1) binds the urokinase-type plasminogen activator (uPA) and causes its degradation via its receptor uPAR and low-density lipoprotein receptor-related protein (LRP). While both uPA and PAI-1 are chemoattractants, we find that a preformed uPA-PAI-1 complex has no chemotactic activity and that PAI-1 inhibits uPA-induced chemotaxis. The inhibitory effect of PAI-1 on uPA-dependent chemotaxis is reversed when uPAR internalization is inhibited by the 39 kDa receptor-associated protein or by anti-LRP antibodies. Under the same conditions, the uPA-PAI-1 complex is turned into a chemoattractant causing cytoskeleton reorganization and extracellular-regulated kinase/mitogen-activated protein kinases activation. Thus, uPAR internalization by PAI-1 regulates cell migration. (C) 2001 Published by Elsevier Science B.V. on behalf of the Federation of European Biochemical Societies.
引用
收藏
页码:249 / 254
页数:6
相关论文
共 37 条
[11]   Src-dependence and pertussis toxin sensitivity of urokinase receptor-dependent chemotaxis and cytoskeleton reorganization in rat smooth muscle cells [J].
Degryse, B ;
Resnati, M ;
Rabbani, SA ;
Villa, A ;
Fazioli, F ;
Blasi, F .
BLOOD, 1999, 94 (02) :649-662
[12]   The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells [J].
Degryse, B ;
Bonaldi, T ;
Scaffidi, P ;
Müller, S ;
Resnati, M ;
Sanvito, F ;
Arrigoni, G ;
Bianchi, ME .
JOURNAL OF CELL BIOLOGY, 2001, 152 (06) :1197-1206
[13]   Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release? [J].
Deng, G ;
Curriden, SA ;
Wang, SJ ;
Rosenberg, S ;
Loskutoff, DJ .
JOURNAL OF CELL BIOLOGY, 1996, 134 (06) :1563-1571
[14]   A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity [J].
Fazioli, F ;
Resnati, M ;
Sidenius, N ;
Higashimoto, Y ;
Appella, E ;
Blasi, F .
EMBO JOURNAL, 1997, 16 (24) :7279-7286
[15]   Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling [J].
Ghiso, JAA ;
Kovalski, K ;
Ossowski, L .
JOURNAL OF CELL BIOLOGY, 1999, 147 (01) :89-103
[16]   THE ACUTE PROMYELOCYTIC LEUKEMIA-SPECIFIC PML-RAR-ALPHA FUSION PROTEIN INHIBITS DIFFERENTIATION AND PROMOTES SURVIVAL OF MYELOID PRECURSOR CELLS [J].
GRIGNANI, F ;
FERRUCCI, PF ;
TESTA, U ;
TALAMO, G ;
FAGIOLI, M ;
ALCALAY, M ;
MENCARELLI, A ;
GRIGNANI, F ;
PESCHLE, C ;
NICOLETTI, I ;
PELICCI, PG .
CELL, 1993, 74 (03) :423-431
[17]   Urokinase receptor-deficient mice have impaired neutrophil recruitment in response to pulmonary Pseudomonas aeruginosa infection [J].
Gyetko, MR ;
Sud, S ;
Kendall, T ;
Fuller, JA ;
Newstead, MW ;
Standiford, TJ .
JOURNAL OF IMMUNOLOGY, 2000, 165 (03) :1513-1519
[18]   Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans - A murine transgenic model [J].
Gyetko, MR ;
Chen, GH ;
McDonald, RA ;
Goodman, R ;
Huffnagle, GB ;
Wilkinson, CC ;
Fuller, JA ;
Toews, GB .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (08) :1818-1826
[19]   VERY-LOW-DENSITY LIPOPROTEIN RECEPTOR BINDS AND MEDIATES ENDOCYTOSIS OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR-TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR COMPLEX [J].
HEEGAARD, CW ;
SIMONSEN, ACW ;
OKA, K ;
KJOLLER, L ;
CHRISTENSEN, A ;
MADSEN, B ;
ELLGAARD, L ;
CHAN, L ;
ANDREASEN, PA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (35) :20855-20861
[20]   PURIFICATION OF UROKINASE BY AFFINITY CHROMATOGRAPHY [J].
HOLMBERG, L ;
BLADH, B ;
ASTEDT, B .
BIOCHIMICA ET BIOPHYSICA ACTA, 1976, 445 (01) :215-222